Wird geladen...
Oral tapentadol for cancer pain
BACKGROUND: A large proportion of people with advanced cancer will experience moderate to severe pain. Tapentadol is a novel, centrally acting analgesic medicine acting at the μ‐opioid receptor and inhibiting noradrenaline reuptake. The efficacy of tapentadol is stated to be comparable to morphine a...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2015
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483480/ https://ncbi.nlm.nih.gov/pubmed/26403220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011460.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|